Relaxin: A Novel Agent for the Treatment of Acute Heart Failure

E-ISSN： 1875-9114|35|3|315-327

ISSN： 0277-0008

Source： PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol.35, Iss.3, 2015-03, pp. : 315-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and tolerability of serelaxin, a recombinant human relaxin‐2 in development for the treatment of acute heart failure, in healthy Japanese volunteers and a comparison of pharmacokinetics and pharmacodynamics in healthy Japanese and Caucasian populations

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 4, 2015-04 ,pp. : 415-422

John Wiley & Sons Inc

Access to resources Recommend Favorite

Underutilization of IV Nitrates in the Treatment of Acute Heart Failure

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 33, Iss. 4, 2015-08 ,pp. : 247-252

John Wiley & Sons Inc

Access to resources Recommend Favorite

Medical and Ventilatory Treatment of Acute Heart Failure: New Insights

Cardiology, Vol. 106, Iss. 1, 2006-07 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

Novel approach for heart failure treatment after liver transplantation

LIVER TRANSPLANTATION, Vol. 21, Iss. 8, 2015-08 ,pp. : 1103-1104

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence and Predictors of Development of Acute Renal Failure Related to Treatment of Congestive Heart Failure with ACE Inhibitors

Nephron Clin Pract, Vol. 105, Iss. 2, 2006-12 ,pp. : c77-c83

Karger

Access to resources Recommend Favorite